About Us
Team
Pipeline
News
Contact Us
Home
Management Team
Board of Directors
Key Consultants
Kinex raises more than $3 million in equity financing
Kinex Co-Founder Appointed to NYBA Board
Kinex Awarded US Patent
Start of Clinical Trial for KX2-391
KX2-391 Enters Phase 1 Clinical Trials for Oncology
More headlines ...
Key Consultants
Gilad S. Gordon, M.D.
©2007 Kinex Pharmaceuticals. All rights reserved.
